Patient treatments on the TomoHD treatment system are expected to commence in March. HKSH plans to install the second TomoHD treatment system later in 2011.
"TomoTherapy is very pleased to announce the shipment of our 350th treatment system, a key milestone in both the adoption and evolution of our radiation therapy platform," said Fred Robertson, TomoTherapy's president and CEO. "We are equally pleased to announce the first dual order of TomoHD treatment systems worldwide. Hong Kong Sanatorium is another longstanding partner that has chosen to embrace the increased flexibility and throughput capabilities that the TomoHD system offers. We look forward to bringing this technology to Hong Kong."
Ad Statistics
Times Displayed: 64511
Times Visited: 2110 Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.
About Hong Kong Sanatorium and Hospital
Hong Kong Sanatorium & Hospital (HKSH) is one of the leading private hospitals in Hong Kong. HKSH is committed to ensuring quality in service and excellence in care. It also strives to advance in medical education and research, with an overriding concern for the public good. For more details, please visit www.hksh.com/eng.
About TomoTherapy Incorporated
TomoTherapy Incorporated develops, markets and sells advanced radiation therapy solutions that can be used to treat a wide variety of cancers, from the most common to the most complex. The ring gantry-based TomoTherapy® platform combines integrated CT imaging with conformal radiation therapy to deliver sophisticated radiation treatments with speed and precision while reducing radiation exposure to surrounding healthy tissue. TomoTherapy's suite of solutions include its flagship Hi·Art® treatment system, which has been used to deliver more than three million CT-guided, helical intensity-modulated radiation therapy (IMRT) treatment fractions; the TomoHD™ treatment system, designed to enable cancer centers to treat a broader patient population with a single device; and the TomoMobile™ relocatable radiation therapy solution, designed to improve access and availability of state-of-the-art cancer care.
TomoTherapy's stock is traded on the NASDAQ Global Select Market under the symbol TOMO. To learn more about TomoTherapy, please visit TomoTherapy.com.
Back to HCB News
